Afuco™ Anti-IL31 ADCC Therapeutic Antibody (Lokivetmab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL31. Lokivetmab is a caninized monoclonal antibody that can be potentially used in the treatment of Canine atopic dermatitis (AD).
Supplier | Creative Biolabs |
---|---|
Product # | AFC-TAB-419CQ |
Pricing | Inquiry |
Host | Canine |
Target | IL31 |
Species Reactivity | Canine |
Type | ADCC enhanced antibody |
Applications | ELISA, IHC, FC, IP, IF, FuncS |
Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |